Ionis Pharmaceuticals (IONS) Change in Acquisitions & Divestments (2009 - 2026)

Ionis Pharmaceuticals' Change in Acquisitions & Divestments history runs 18 years deep, the most recent figure standing at $752.8 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 52.16% year-over-year to $752.8 million in Q1 2026; TTM through Mar 2026 was $2.0 billion, a 17.61% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, down 4.03% from the prior year.
• Change in Acquisitions & Divestments rose to $752.8 million in Q1 2026 per IONS's latest filing, from $395.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $752.8 million in Q1 2026 and bottomed at $178.8 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $385.8 million (2025), against an average of $399.6 million.
• Across the five-year window, Change in Acquisitions & Divestments slumped 56.58% in 2022 and surged 109.33% in 2023, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $225.1 million in 2022, then soared by 73.72% to $391.0 million in 2023, then increased by 9.96% to $429.9 million in 2024, then slipped by 8.09% to $395.1 million in 2025, then surged by 90.53% to $752.8 million in 2026.
• Per Business Quant, the three latest IONS Change in Acquisitions & Divestments figures stand at $752.8 million (Q1 2026), $395.1 million (Q4 2025), and $422.2 million (Q3 2025).